Symbol="FNCH"
AssetType="Common Stock"
Name="Finch Therapeutics Group Inc"
Description="Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutic company, is developing a new class of orally administered biologic drugs in the United States. The company is headquartered in Somerville, Massachusetts."
CIK="1733257"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="200 INNER BELT ROAD, SOMERVILLE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="10046100"
EBITDA="-83095000"
PERatio="None"
PEGRatio="None"
BookValue="59.75"
DividendPerShare="0"
DividendYield="0"
EPS="-99.89"
RevenuePerShareTTM="0.542"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.391"
ReturnOnEquityTTM="-1.448"
RevenueTTM="614000"
GrossProfitTTM="-57032000"
DilutedEPSTTM="-99.89"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.698"
AnalystTargetPrice="150"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="23.38"
PriceToBookRatio="0.362"
EVToRevenue="6.54"
EVToEBITDA="-0.132"
Beta="0.155"
num_52WeekHigh="86.7"
num_52WeekLow="6.25"
num_50DayMovingAverage="8.38"
num_200DayMovingAverage="14.71"
SharesOutstanding="1604800"
DividendDate="None"
ExDividendDate="None"
symbol="FNCH"
open="6.61"
high="6.61"
low="6.26"
price="6.26"
volume="1446.00"
latest_trading_day="2023-08-15"
previous_close="6.48"
change="-0.22"
change_percent="-3.3966%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="85"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="15"
Volume_recent_avg="188386"
Change_recent_avg="0.02"
Delta_recent_avg="0.34"
Variance_recent_avg="0.17"
Change_ratio_recent_avg="0.79"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="15"
Aroon_momentum_negative="85"
image_negative_thumbnail_id_1="1133"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0166.jpeg"
image_negative_thumbnail_id_2="1091"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0124.jpeg"
image_neutral_thumbnail_id_1="545"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_neutral_thumbnail_id_2="532"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_positive_thumbnail_id_1="689"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0019.jpeg"
image_positive_thumbnail_id_2="991"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0153.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
